Clinical Trials Directory

Trials / Completed

CompletedNCT06621069

The Effect of Long-term Use of Bisphosphonates on Femur Morphology

Status
Completed
Phase
Study type
Observational
Enrollment
140 (actual)
Sponsor
Second Affiliated Hospital, School of Medicine, Zhejiang University · Academic / Other
Sex
All
Age
Healthy volunteers
Accepted

Summary

Recent studies have shown that bone modeling can occur throughout life, suggesting bone has a persistent ability of adapting structure to loading. Some bone medications have a significant effect on the process of bone modeling based on histological studies. Bisphosphonates (BP), a classical anti-resorption drug which impacts the process of bone turnover, is related with atypical femur fractures while the mechanism is unclear. Several hypotheses are considered competitive. Among them, increased femur bowing is associated with atypical femoral fractures. However, it remains doubtful whether long-term BP use increases femur bowing. Thus, the investigators design this retrospective cohort study.

Detailed description

If the participants meet the Inclusion Criteria, the investigators will collect the baseline characteristics of patients including age, gender, body mass index (BMI), as well as characteristics of BMD by dual-energy X-ray absorptiometry (DXA), BP treatment (type of drugs, duration before baseline). The primary outcome was femoral lateral bowing (FLB), femoral neck shaft angle (FNSA), and hip knee shaft angle (HKSA) from the frontal plane in standing radiographs of the lower limbs.

Conditions

Interventions

TypeNameDescription
DRUGBisphosphonatesAlendronate Sodium or Zoledronic acid
OTHERControlcontrol without BP

Timeline

Start date
2024-06-01
Primary completion
2024-07-01
Completion
2024-08-01
First posted
2024-10-01
Last updated
2024-10-01

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06621069. Inclusion in this directory is not an endorsement.